Melbourne breast cancer trial to test Optiscan imaging device

Optiscan says bringing its technology into operating theatres could be transformative as it has the potential to bridge the gap between diagnostic imaging and surgical decision-making, which could significantly reduce the reliance on post-operative pathology.It says the process could improve a…


Click here to view the original article.